PCSK9 & LDL- The best story of translational medicine?
Dr Evan Stein, Cincinnati, Ohio, USA with a short overview of the current status of development of PCSK9 inhibitors.
Soon a video presentation will be posted
Soon a video presentation will be posted
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: